Christian Winther Eskelund, Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Lone Bredo Pedersen, Christian Hartmann Geisler, Mats Jerkeman, and Kirsten Grønbæk. 2018. “Lenalidomide Plus Bendamustine-Rituximab Does Not Overcome the Adverse Impact of TP53 Mutations in Mantle Cell Lymphoma”. Haematologica 103 (11). Pavia, Italy, e541-e543. https://doi.org/10.3324/haematol.2018.194399.